Zuranolone

Pre-clinicalRecruiting

0 views this week 0 watching💤 Quiet

Interest: 30/100

Hype Score

Development Stage

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Depression, Postpartum

Conditions

Depression, Postpartum

Trial Timeline

Jun 30, 2025 → Aug 24, 2026

NCT ID

NCT07047820

About Zuranolone

Zuranolone is a pre-clinical stage product being developed by Biogen for Depression, Postpartum. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07047820. Target conditions include Depression, Postpartum.

What happened to similar drugs?

13 of 20 similar drugs in Depression, Postpartum were approved

Approved (13) Terminated (2) Active (6)

🔄Olanzapine and Fluoxetine combination (OFC) + FluoxetineEli LillyPhase 3

✅DuloxetineEli LillyApproved

🔄FK949EAstellas PharmaPhase 3

🔄duloxetine + escitalopram + placeboEli LillyPhase 3

✅duloxetineEli LillyApproved

🔄Duloxetine HydrochlorideEli LillyPhase 3

✅DuloxetineEli LillyApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (3)

NCT ID	Phase	Status	Start	Completion	Indication
NCT07398469	Pre-clinical	Recruiting	Dec 22, 2025	Mar 29, 2027	Postpartum Depression
NCT07047820	Pre-clinical	Recruiting	Jun 30, 2025	Aug 24, 2026	Depression, Postpartum
NCT05655507	Phase 1	Completed	Apr 19, 2023	Oct 18, 2024	Major Depressive Disorder

Competing Products

20 competing products in Depression, Postpartum

See all competitors

Product	Company	Stage	Hype Score
Olanzapine and Fluoxetine combination (OFC) + Fluoxetine	Eli Lilly	Phase 3	40
Duloxetine	Eli Lilly	Approved	35
FK949E	Astellas Pharma	Phase 3	40
Quetiapine	Astellas Pharma	Pre-clinical	26
duloxetine + escitalopram + placebo	Eli Lilly	Phase 3	40
duloxetine	Eli Lilly	Approved	43
Duloxetine Hydrochloride	Eli Lilly	Phase 3	40
Duloxetine	Eli Lilly	Approved	43
Duloxetine	Eli Lilly	Approved	43
Venlafaxine (Effexor), Duloxetine (Cymbalta), Escitalopram (Lexapro)	Eli Lilly	Approved	43
Duloxetine + Placebo	Eli Lilly	Phase 3	40
Duloxetine	Eli Lilly	Approved	43
duloxetine + fluoxetine + citalopram + paroxetine + sertraline	Eli Lilly	Approved	43
Olanzapine + Placebo	Eli Lilly	Phase 3	40
Olanzapine + Fluoxetine + Placebo	Eli Lilly	Phase 3	32
duloxetine + duloxetine	Eli Lilly	Pre-clinical	26
olanzapine + ziprasidone	Eli Lilly	Approved	43
Olanzapine Fluoxetine Combination (OFC) + Placebo	Eli Lilly	Approved	43
Drug treatment with Cymbalta	Eli Lilly	Approved	39
Duloxetine	Eli Lilly	Approved	43